Tag: bioequivalence waivers
IVIVC and Waivers: How In Vitro Methods Are Replacing In Vivo Bioequivalence Testing
IVIVC lets pharmaceutical companies predict how a drug behaves in the body using lab-based dissolution tests, replacing costly and time-consuming human trials. When done right, it saves millions and speeds up generic drug approval.
read morerecent posts
Counterfeit medications are a growing global threat, with millions of fake pills and injections seized each year. Real cases from 2025 reveal how dangerous these fakes are-and what we must do to stop them.
Published ON: 3 MarPhysicians prescribing generic medications now face rising legal liability as federal rulings shield drug manufacturers from lawsuits. Learn how to protect yourself with proper documentation and prescribing practices.
Published ON: 10 MarLearn the critical difference between medication side effects and adverse drug reactions - why confusing them can lead to unnecessary panic, wrong decisions, and even dangerous health outcomes. Clear, science-backed explanation for patients and caregivers.
Published ON: 6 MarBioequivalence testing for combination products like FDCs, inhalers, and topical creams is far more complex than for single-drug generics. Regulatory, technical, and financial hurdles delay affordable access to life-saving medications.
Published ON: 13 MarNasal congestion from overused decongestant sprays is common and reversible. Learn how rebound congestion works, why stopping the spray is the only cure, and what actually helps you recover - backed by clinical evidence.
Published ON: 5 Mar